3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Rectal Neoplasms
3
Colorectal Neoplasms
3
Stomach Neoplasms
2
Neoplasm, Residual
2
Mesothelioma, Malignant
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Sarcopenia
1
Sarcoglycanopathies
1
Peritoneal Neoplasms
1
Pancreatic Neuroendocrine Tumors (pNET)
1
Pancreatic Neoplasms
1
Nasopharyngeal Carcinoma
1
NSCLC
1
Mesothelioma
1
Melanoma
1
Malnutrition
1
Lung Neoplasms
1
HER2 Negative Breast Cancer
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Frailty
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Interventions
pembrolizumab
2
enzalutamide
2
abiraterone
2
Immune Checkpoint Inhibitors
2
Cytochrome P-450 Enzyme System
2
durvalumab
1
dostarlimab
1
cemiplimab
1
blinatumomab
1
atezolizumab
1
Surgical Instruments
1
Hydroxyurea
1
Etoposide
1
Etanercept
1
Carboplatin
1
Androgen Receptor Antagonists
1
AMG 757
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Bites and Stings
×
Chemotherapy, Adjuvant
×
1 year
×
Clear all
No trials found.